NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM1123514 Query DataSets for GSM1123514
Status Public on Feb 24, 2014
Title Matched Control Group [cv000565 baseline]
Sample type RNA
 
Source name Blood - PaxGene
Organism Homo sapiens
Characteristics group: Matched Control Group
age: 66.84
gender: Male
cad: Yes
diabetes: No
1 year weight loss (%): -1.44
Treatment protocol Participants were enrolled on an ongoing basis in a lifestyle intervention that consisted of four components: 1) a very low fat vegetarian diet (<10% of calories from fat); 2) 180 minutes/week of moderate aerobic exercise; 3) one hour of stress management each day; and 4) weekly group support sessions (40). Clinical staff met with patients twice each week during the first 12 weeks to orient participants to the program and maximize adherence. The remainder of the program was primarily self-directed but included ongoing weekly stress management and group support sessions.
Growth protocol N/A
Extracted molecule total RNA
Extraction protocol Qiagen PAXgene™ Blood RNA System
Label Biotin
Label protocol double-stranded cDNA (1 ug) labeled with biotin-11-UTP using MessageAmp™ II aRNA Amplification System (Ambion)
 
Hybridization protocol Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C onGeneChip® Human Genome U133A 2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
Scan protocol scanned on a GeneChip® Scanner 3000.
Description Gene Expression Data from a matched Control Group participant
Data processing Partek® Genomics Suite v6.5 (Partek Incorporated) was used to analyze gene expression data from the 378 CEL files, which all passed standard QC assessment. Duplicate blood samples collected at each time point from 7 random participants indicated high repeatability of the microarray data (average Pearson correlation of normalized intensities was 0.992 + 0.006, range 0.969-0.996). Paired t-tests identified 9 genes that were excluded from further analysis because they showed significant differences in expression among duplicate samples based on a false discovery rate (FDR) adjusted P-value <0.05
 
Submission date Apr 16, 2013
Last update date Feb 20, 2015
Contact name Darrell Ellsworth
E-mail(s) d.ellsworth@wriwindber.org
Organization name Windber Research Institute
Street address 620 Seventh St.
City Windber
State/province PA
ZIP/Postal code 15963
Country USA
 
Platform ID GPL571
Series (2)
GSE46097 Expression data of Participants of Ornish intervention and Control group
GSE66175 Imporatance of substantial weight loss for altering gene expression during intensive cardiovascular lifestyle modification

Data table header descriptions
ID_REF
VALUE log2 RMA, standard settings as implemented in Partek

Data table
ID_REF VALUE
1007_s_at 6.12291
1053_at 6.86056
117_at 9.08524
121_at 6.95997
1255_g_at 2.51109
1294_at 8.56932
1316_at 4.79482
1320_at 3.42515
1405_i_at 11.7706
1431_at 3.38103
1438_at 4.36344
1487_at 7.51879
1494_f_at 4.4812
1598_g_at 7.20821
160020_at 6.22597
1729_at 8.84793
1773_at 5.24974
177_at 4.02239
179_at 7.29931
1861_at 6.88353

Total number of rows: 22277

Table truncated, full table size 409 Kbytes.




Supplementary file Size Download File type/resource
GSM1123514_565_Baseline_JW013008.CEL.gz 1.8 Mb (ftp)(http) CEL
GSM1123514_565_Baseline_JW013008MR.CHP.gz 122.0 Kb (ftp)(http) CHP
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap